-transparent.png){kind=logo}
Twenty-one (three groups of seven), men and women, 25-50 years of age were studied to determine whether or not rebound insomnia would increase the likelihood of self administering a benzodiazepine (triazolam 0.25 mg) hypnotic. The groups compared were patients with insomnia and disturbed sleep, insomnia and normal sleep, and healthy normals. Rebound insomnia, by both subjective and polysomnographic assessment, was induced. The experience of rebound insomnia did not increase the likelihood of self administering a benzodiazepine hypnotic in any of the groups. There were clear group differences in pill self administration with normals rarely and insomnia patients frequently, but not differentially (placebo versus active drug) self administering pills.
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
January 1998,
European archives of psychiatry and clinical neuroscience,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
October 1980,
Deutsche medizinische Wochenschrift (1946),
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
April 1980,
Science (New York, N.Y.),
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
April 1980,
Science (New York, N.Y.),
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
September 1996,
Psychopharmacology,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
April 2001,
Psychopharmacology,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
January 1983,
Pharmacology,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
January 2002,
Sleep medicine,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
May 2002,
Psychopharmacology,
T Roehrs, and
L Merlotti, and
F Zorick, and
T Roth
August 1999,
Primary care companion to the Journal of clinical psychiatry,
